Biological effects of IL-21 on immune cells and its potential for cancer treatment

Interleukin-21 (IL-21), a member of the IL-2 cytokine family, is one of the most important effector and messenger molecules in the immune system. Produced by various immune cells, IL-21 has pleiotropic effects on innate and adaptive immune responses via regulation of natural killer, T, and B cells. An anti-tumor role of IL-21 has also been reported in the literature, as it may support cell proliferation or on the contrary induce growth arrest or apoptosis of the tumor cell. Anti-tumor effect of IL-21 enhances when combined with other agents that target tumor cells, immune regulatory circuits, or other immune-enhancing molecules. Therefore, understanding the biology of IL-21 in the tumor microenvironment (TME) and reducing its systemic toxic and side effects is crucial to ensure the maximum benefits of anti-tumor treatment strategies. In this review, we provide a comprehensive overview on the biological functions, roles in tumors, and the recent advances in preclinical and clinical research of IL-21 in tumor immunotherapy.

Automated summary

Interleukin-21 (IL-21) is an important effector and messenger molecule in the immune system, with pleiotropic effects on innate and adaptive immune responses. It plays a role in regulating natural killer, T, and B cells. IL-21 also has anti-tumor effects and can enhance the effectiveness of other anti-tumor agents. Understanding the biology of IL-21 in the tumor microenvironment and reducing its toxic and side effects is crucial for maximum benefits in anti-tumor treatment strategies.